MarketPeel
Insider Trading Intelligence
AK

Anatol Kreitzer

MPLT
CHIEF DISCOVERY OFFICER · MAPLIGHT THERAPEUTICS, INC. · CIK 0002021238
FILING MIX · LIFETIME25%/75%
BUYS
4
SELLS
12
TOTAL VALUE
$3.54M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
175,106
AVG SELL PX
$27.83
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Anatol Kreitzer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%-0.11%+0.70%-0.81%-7.02%
14d4+75.00%+1.80%+2.95%-1.14%-5.17%
30d4+75.00%-0.67%+6.05%+2.83%+2.83%
60d4+75.00%-3.35%+3.50%-6.84%-9.20%
90d4+0.00%+26.03%+4.25%+21.78%+16.00%
180d4(4 pending)
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MPLT · 175,106 shares · as of Jul 17, 2026
064,982129,964194,946259,9282026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2026
2026
2026
FLOW · 4 buys / 12 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,140$37.70$533.1K175,106Jul 17, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
200$38.39$7.7K174,906Jul 17, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,833$37.05$105.0K189,246Jul 17, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Discovery Officer
7,464$36.66$273.6K193,671Jul 16, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Discovery Officer
1,592$37.44$59.6K192,079Jul 16, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Discovery Officer
4,510$36.94$166.6K201,135Jul 15, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Discovery Officer
5,545$36.13$200.3K205,645Jul 15, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,346$28.96$241.7K248,266Apr 27, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,821$30.50$238.5K211,190Apr 27, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
29,255$29.63$866.8K219,011Apr 27, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Discovery Officer
3,316$26.61$88.2K256,612Apr 15, 2026Apr 17, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,020259,928Feb 5, 2026Feb 9, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,45524,455Feb 5, 2026Feb 9, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
Chief Discovery Officer
42,099$17.98$756.9K253,908Jan 27, 2026Jan 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
146,052146,052Oct 27, 2025Oct 28, 2025View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,95335,953Oct 27, 2025Oct 28, 2025View →
Other insiders · MPLT
Loading peer insiders…
About this filer
CIK 0002021238
ROLE
Chief Discovery Officer
PRIMARY
MPLT
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0002021238DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback